Torres-González L, Muñoz-Espinosa LE, Rivas-Estilla AM, Trujillo-Murillo K, Salazar-Aranda R, Waksman TNCordero-Pérez P

Idioma: Ingles.
Referencias bibliográficas: 45
Paginas: 73-79
Archivo PDF: 75.58 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Williams R. Global challenges in liver disease. Hepatology 2006; 44: 521-6.

2. Méndez-Sánchez N, Villa AR, Chavéz-Tapia NC, Ponciano- Rodriguez G, Almeda-Valdés P, González D, Uribe M. Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. Ann Hepatol 2005; 4: 52-5.

3. Foster BC, Arnason JT, Briggs CJ. Natural health products and drug disposition. Annu Rev Pharmacol Toxicol 2005; 45: 203-26.

4. Matteuci E, Giampietro O. Proposal open for discussion: defining agreed diagnostic procedures in experimental diabetes research. J Ethnopharmacol 2008; 115: 163-72.

5. Hamilton AC. Medicinal plants, conservation and livelihoods. Biodiversity and Conservation 2004; 13: 1477-517.

6. Lee KH. Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach. J Nat Prod 2010; 73: 500-16.

7. Johnson JJ, Bailey HH, Mukhtar H. Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine 2010; 17: 3-13.

8. Tolstikova TG, Khvostov MV, Bryzgalov AO. The complexes of drugs with carbohydrate-containing plant metabolites as pharmacologically promising agents. Mini Rev Med Chem 2009; 9: 1317-28.

9. Oliver-Bever B. Drugs plants in ancient and modern Mexico. Annu Rev Pharmacol Toxicol 1972; 12: 1957-72.

10. De Micheli A, Izaguirre-Avila R. On Mexican medicinal plants. Arch Cardiol Mex 2009; 79: 95-101.

11. García-Alvarado SJ, Verde-Star MJ, Herendia NL. Traditional uses and scientific knowledge of medicinal plants from Mexico and Central America. J Herbs Spices Med Plants 2001; 8: 37-89.

12. Salazar R, Pozos ME, Cordero P, Perez J, Salinas MC, Waskman N. Determination of the antioxidant activity of six plants from Northeast Mexico. Pharm Biol 2008; 46: 166-70.

13. Lee SE, Hwang HJ, Ha JS, Jeong HS, Kim JH. Screening of medicinal plant extracts for antioxidant activity. Life Sci 2003; 73: 167-79.

14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.

15. Gómez-Lechón MJ, Lahoz A, Gombau L, Castell JV, Donato MT. In vitro evaluation of potential hepatotoxicity induced by drugs. Curr Pharm Des 2010; 16: 1963-77.

16. Kikkawa R, Yamamoto T, Fukushima T, Yamada H, Horii I. Investigation of a hepatotoxicity screening system in primary cell cultures - “What biomarkers would need to be addressed to estimate toxicity in conventional and new approaches?” J Toxicol Sci 2005; 30: 61-72.

17. Groneberg DA, Grosee-Siestrup C, Fischer A. In vitro models to study hepatotoxicity. Toxicol Pathol 2002; 30: 394-9.

18. Dambach DM, Andrews BA, Moulin F. New technologies and screening strategies for hepatotoxicity: use of in vitro models. Toxicol Pathol 2005; 33: 17-26.

19. Luper S. A review of plants used in the treatment of liver disease: Part 1. Altern Med Rev 1998; 3: 410-21.

20. Luper S. A review of plants used in the treatment of liver disease: Part Two. Altern Med Rev 1999; 4: 178-88.

21. Hamburger M, Hostettmann K. Bioactivity in plants: the link between phytochemistry and medicine. Phytochemistry 1991; 30: 3864-74.

22. Schuppan D, Jia JD, Brinkhaus B, Hahn EG. Herbal products for liver diseases: a therapeutic challenge for the new millennium. Hepatology 1999; 30: 1099-104.

23. Seeff LB, Lindsay KL, Bacon BR, Kresina TF, Hoofnagle JH. Complementary and alternative medicine in chronic liver disease. Hepatology 2001; 34: 595-603.

24. Pietta PG. Flavonoids as antioxidants. J Nat Prod 2000; 63: 1035-42.

25. Fogden E, Neuberger J. Alternative medicine and the liver. Liver Int 2003; 23: 213-20.

26. Ball KR, Kowdley K. A review of Silybum marianum (milk thistle) as a treatment for alcoholic liver disease. J Clin Gastroenterol 2005; 39: 520-8.

27. Mayer KE, Myers RP, Lee SS. Silymarin treatment of viral hepatitis: a systematic review. J Viral Hepat 2005; 12: 559-67.

28. Koleva II, Van Beek T, Linssen J P, De Groot A, Evstatieva LN. Screening of plant extracts for antioxidant activity: a comparative study on three testing methods. Phytochem Anal 2001; 13: 8-17.

29. Kiso Y, Tohkin M, Hikino H. Assay method for antihepatotoxic activity using carbon tetrachloride induced cytotoxicity in primary cultured hepatocytes. Planta Med 1983; 49: 222-5.

30. Slater TF, Cheeseman KH, Ingold KU. Carbon tetrachloride toxicity as a model for studying free-radical mediated liver injury. Phil Trans R Soc Lond B Bio Sci 1985; 311: 633-45.

31. Weber LW, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 2003; 33: 105-36.

32. Dandagi PM, Patil MB, Mastiholimath VS, Gadad AP, Dhumansure RH. Development and evaluation of hepatoprotective polyherbal formulation containing some indigenous medicinal plants. Indian J Pharm Sci 2008; 70: 265-8.

33. Shyamal S, Latha PG, Shine VJ, Suja SR, Rajasekharan S, Ganga Devi T. Hepatoprotective effects of Pittosporum neelgherrense Wight&Arn., a popular Indian ethnomedicine. J Ethnopharmacol 2006; 107: 151-5.

34. Abenavoli L, Capasso R, Milic N, Capasso F. Milk thistle in liver disease: past, present, future. Phytother Res 2010. In press.

35. Mayer KE, Myers RP, Lee SS. Silymarin treatment of viral hepatitis: a systematic review. J Viral Hepat 2005; 12: 559-67.

36. USDA-ARS-GRIN Database, 2006. USDA, ARS, National Genetic Resources Program, Germplasm Resources Information Network (GRIN). National Germplasm Resources Laboratory, Beltsville, MD, USA. Available from: .

37. Heinrich M, Robles M, West JE, Ortiz de Montellano BR, Rodriguez E. Ethnopharmacology of Mexican Asteraceae (Compositae). Annu Rev Pharmacol Toxicol 1998; 38: 539-65.

38. Shoeb M, MacManus SM, Kumarasamy Y, Jaspars M, Nahar L, Thoo-Lin PK, Nazemiyeh H, et al. Americanin, a bioactive dibenzylbutyrolactone lignan, from the seeds of Centaurea americana. Phytochemistry 2006; 67: 2370-5.

39. Ren-Bo A, Hyun-Chul K, Yu-Hua T, Youn-Chul K. Free radical scavenging and hepatoprotective constituents from the leaves of Juglans sinensis. Arch Pharm Res 2005; 28; 529-33.

40. Fukuda T, Ito H, Yoshida T. Antioxidative polyphenols from walnuts (Juglans regia L.). Phytochemistry 2003; 63: 795-801.

41. Carvalho M, Ferreira PJ, Mendes VS, Silva R, Pereira JA, Jerónimo C, Silva BM. Human cancer cell antiproliferative and antioxidant activities of Juglans regia L. Food Chem Toxicol 2010; 48: 441-7.

42. Asgary S, Parkhideh S, Solhpour A, Madani H, Mahzouni P, Rahimi P. Effect of ethanolic extract of Juglans regia L. on blood sugar in diabetes-induced rats. J Med Food 2008; 11: 533-8.

43. Aradhya MK, Potter D, Gao F, Simon CJ. Molecular phylogeny of Juglans (Juglandaceae): a biogeographic perspective. Tree Genet. Genomes 2007; 3: 363-78.

44. Fernandez R, Ramos D. Notas sobre plantas medicinales del estado de Querétaro, México. Polibotánica 2001; 12: 1-40.

45. Cruz-Vega DE, Verde-Star MJ, Salinas-González N, Rosales- Hernández B, Estrada-García I, Mendez-Aragón P, Carranza- Rosales P, et al. Antimycobacterial activity of Juglans regia, Juglans mollis, Carya illinoensis and Bocconia frutescens. Phytother Res 2008; 22: 557-9.